1,250
Participants
Start Date
December 31, 2002
Primary Completion Date
October 31, 2009
Study Completion Date
October 31, 2009
Abatacept
Intravenous (IV) Solution, - Weight Titered (500 mg \< 60 kg); (750 mg 60-100 kg), )1 gram \> 100 kg), Day 1, Day 15, Day 29; every 28 days thereafter, 1 year
Methotrexate
Tablets, Oral, \>= 15 mg, weekly, 1 year
Placebo
IV solution, Intravenous, D5W, Day 1, Day 15, Day 29; every 28 days thereafter, 1 year
Local Institution, Birmingham
Local Institution, Huntsville
Local Institution, Mobile
Local Institution, Phoenix
Local Institution, Scottsdale
Local Institution, Corona
Local Institution, Irvine
Local Institution, La Jolla
Local Institution, Long Beach
Local Institution, Rancho Mirage
Local Institution, Aurora
Local Institution, Colorado Springs
Local Institution, Denver
Local Institution, Hamden
Local Institution, Washington D.C.
Local Institution, Fort Lauderdale
Local Institution, Gainsville
Local Institution, Palm Harbor
Local Institution, Sarasota
Local Institution, St. Petersburg
Local Institution, Chicago
Local Institution, Rockford
Local Institution, Wichita
Local Institution, Coeur d'Alene
Local Institution, Cumberland
Local Institution, Springfield
Local Institution, Duluth
Local Institution, Lincoln
Local Institution, New Brunswick
Local Institution, Albuquerque
Local Institution, Albany
Local Institution, Binghamton
Local Institution, Mineola
Local Institution, New York
Local Institution, Syracuse
Local Institution, The Bronx
Local Institution, Wilmington
Local Institution, Cincinnati
Local Institution, Oklahoma City
Local Institution, Duncansville
Local Institution, Norristown
Local Institution, Sellersville
Local Institution, Willow Grove
Local Institution, North Charleston
Local Institution, Austin
Local Institution, San Antonio
Local Institution, Arlington
Local Institution, Milwaukee
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY